表紙
市場調查報告書
商品編碼
1021662

生殖器疣治療市場:藥物類型,流通管道,各地區-規模,佔有率,展望,機會分析(2021年∼2028年)

Genital Warts Treatment Market, by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 149 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

生殖器疣是一種常見的性傳播感染(STI),透過陰道和肛門性交、共用性玩具傳播,很少透過口交傳播。有多種治療方法可用於治療生殖器疣,包括乳膏或液體軟膏、去除疣的手術等。市場參與者著重於開發生殖器疣治療的研究活動。預計這將有助於在預測期內全球生殖器疣治療市場的成長。

本報告提供全球生殖器疣治療市場的相關調查,市場規模和預測,成長及阻礙因素,機會,COVID-19的影響,各藥物類型、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各藥物類型
    • 市場明細:各流通管道
    • 市場明細:各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 成長要素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 流行病學
  • 合併和收購
  • 主要的發展
  • 法規方案
  • PEST分析
  • 償付方案
  • 品牌分析
  • 開發平台分析
  • 治療:概要
  • 生殖器疣患者的治療選擇的演算法

第4章 全球生殖器疣治療市場-冠狀病毒(Covid-19)大流行的影響

  • COVID-19流行病學
  • 需求與供給分析

第5章 全球生殖器疣治療市場:各藥物類型(2021-2028)

  • 簡介
  • Imiquimod
  • Podophyllin和Podofilox
  • 三氯乙酸
  • 抗憂鬱劑
  • 兒茶素
  • 其他

第6章 全球生殖器疣治療市場:各流通管道(2021-2028)

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 全球生殖器疣治療市場:各地區(2021-2028)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 競爭的概述
    • Sanofi SA
    • AbbVie Inc.
    • Perrigo Company PLC
    • 3M
    • Lee's Pharmaceutical Holdings Ltd
    • Cassiopea
    • Glenmark Pharmaceuticals
    • Bausch Health
    • Novartis International AG

第9章 Section

目錄

Genital warts are a common sexually transmitted infection (STI) that is passed on by vaginal and anal intercourse, sharing sex toys, and rarely, by oral sex. There are various treatments that are available for the treatment of genital warts, which include cream or liquid ointments, surgery for removing warts, etc.

Market players are focusing on research activities for the development of treatment for genital warts. This is expected to aid in the growth of the global genital warts treatment market over the forecast period.

For instance, in November 2020, Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced positive results for its Phase II CARE-1 clinical study of VP-102, a novel topical therapy containing a solution of 0.7% (w/v) cantharidin in a proprietary single-use applicator, developed for the treatment of external genital warts (EGW).

VP-102 achieved positive results on both the primary endpoint of complete clearance of all treatable EGW.

Market Dynamics

Market players and research institutes are indulged in conducting research and development, in order to develop treatment for genital warts. This is expected to increase the growth of the global genital warts treatment market over the forecast period.

For instance, in July 2018, Cassiopea SpA, a specialty pharmaceutical company, announced the availability of proof of concept for its Phase II clinical trial of 'CB-06-02', which is a topical 15% immune modulator tellurium-based gel designed for the treatment of genital warts at an extreme level. The proof of concept indicated the complete clearance or statistically significant reduction of genital warts in women. The trial is currently undergoing with various other endpoints.

Key features of the study:

  • This report provides in-depth analysis of the global genital warts treatment market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global genital warts treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Sanofi S.A., AbbVie Inc., Perrigo Company PLC, 3M, Lee's Pharmaceutical Holdings Ltd, Cassiopea, Glenmark Pharmaceuticals, Bausch Health, and Novartis International AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global genital warts treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genital warts treatment market

Detailed Segmentation:

  • Global Genital Warts Treatment Market, By Drug Type:
    • Imiquimod
    • Podophyllin and Podofilox
    • Trichloroacetic Acid
    • Sinecatechins
    • Others
  • Global Genital Warts Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Genital Warts Treatment Market, By Region:
    • North America
      • By Drug Type
      • Imiquimod
      • Podophyllin and Podofilox
      • Trichloroacetic Acid
      • Sinecatechins
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Drug Type
      • Imiquimod
      • Podophyllin and Podofilox
      • Trichloroacetic Acid
      • Sinecatechins
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Type
      • Imiquimod
      • Podophyllin and Podofilox
      • Trichloroacetic Acid
      • Sinecatechins
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Type
      • Imiquimod
      • Podophyllin and Podofilox
      • Trichloroacetic Acid
      • Sinecatechins
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Type
      • Imiquimod
      • Podophyllin and Podofilox
      • Trichloroacetic Acid
      • Sinecatechins
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Type
      • Imiquimod
      • Podophyllin and Podofilox
      • Trichloroacetic Acid
      • Sinecatechins
      • Others
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Sanofi S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • AbbVie Inc.
    • Perrigo Company PLC
    • 3M
    • Lee's Pharmaceutical Holdings Ltd
    • Cassiopea
    • Glenmark Pharmaceuticals
    • Bausch Health
    • Novartis International AG

* marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Epidemiology
  • Mergers and Acquisitions
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Reimbursement Scenario
  • Brand Analysis
  • Pipeline Analysis
  • Therapeutics : Overview
  • Algorithm For Treatment Selection In Patients With Genital Warts

4. Global Genital Warts Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Epidemiology
  • Supply and Demand Analysis

5. Global Genital Warts Treatment Market, By Drug Type, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Imiquimod
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Podophyllin and Podofilox
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Trichloroacetic Acid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Anti-depressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Sinecatechins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)

6. Global Genital Warts Treatment Market, By Distribution Channel, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2028, (US$ Mn)

7. Global Genital Warts Treatment Market, By Region, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2028
  • North America
    • Market Size and Forecast, By Drug Type, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Type, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Type, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Type, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2021 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Region/Country, 2021 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Competitive Snapshot
    • Sanofi S.A.*
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Perrigo Company PLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • 3M
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lee's Pharmaceutical Holdings Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cassiopea
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Glenmark Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bausch Health
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis International AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact